LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
BIOBOARD For e-subscribers (PDF)
Vol 21, No 03, March 2017
Letting Go

Researchers from the Mechanobiology Institute, Singapore (MBI) at the National University of Singapore have described how dying cells detach and are expelled from a tissue, and how tissue tension in the region surrounding a dying cell is remodelled. The work was published online in the scientific journal Development in November 2016. The tissues in our bodies, such as epithelial, nervous or muscle tissue...

ASLAN Pharmaceuticals Announces First Patient Enrolled in Phase 1 Study of Varlitinib in Japan

SINGAPORE - ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, announced that they are initiating enrolment of the first patient in the phase 1 clinical trial for varlitinib (ASLAN001) in biliary tract cancer in Japan. Varlitinib is a potent reversible small molecule inhibitor of the HER-family of...

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

Emeryville, CA and Palo Alto, CA - Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial intelligence-driven biopharmaceutical company, announced on Feb 23 that the two companies have entered into a strategic research collaboration focused on the identification of new drug candidates...

New Study Finds Extensive Use of Fluorinated Chemicals in Fast Food Wrappers

Americans may be consuming fast food wrapped in paper treated with perfluorinated chemicals (PFCs) - the same chemicals used in stain-resistant products, firefighting materials and nonstick cookware, according to a new study published in the journal Environmental Science & Technology. Researchers tested more than 400 samples of packaging materials, including hamburger and sandwich wrappers...

What Doesn't Kill You Makes You Stronger

La Jolla, Calif. - Biologists have known for decades that enduring a short period of mild stress makes simple organisms and human cells better able to survive additional stress later in life. Now, scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have found that a cellular process called autophagy is critically involved in providing the benefits of temporary stress. The study, published in...

Non-Invasive Test Offers Quick Skin Cancer Diagnosis

Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a non-invasive imaging technique that accurately detects skin cancer without surgical biopsy. Multiphoton microscopy of mitochondria-small organelles that produce energy in cells-accurately identified melanomas and basal cell carcinomas by detecting abnormal clusters of mitochondria in...

Life Under Pressure

Washington, D.C. - Life can thrive in some of the most extreme environments on the planet. Microbes flourish inside hot geothermal vents, beneath the frigid ice covering Antarctica and under immense pressures at the bottom of the ocean. For these organisms to survive and function, so must the enzymes that enable them to live and grow. Now, researchers from Georgetown University have homed in on...

Commencement of BIT225 Phase 2 HIV-1 Clinical Trial

Sydney, AUSTRALIA - The Directors of Biotron Limited are pleased to announce that the Company has commenced a Phase 2 human clinical trial (BIT225-009) with its lead antiviral drug BIT225. The trial is a Phase 2, multi-centre, randomised, placebo-controlled, double-blind study of BIT225 and Combination Antiretroviral Therapy (cART): Atripla? in patients with Human Immunodeficiency Virus (HIV-1) infection...

Understanding the Genetics of Human Height

MONTREAL - A large-scale international study involving more than 300 researchers from five continents and 700,000 participants, published on Feb. 1 in Nature, heralds the discovery of 83 genetic variations controlling human height. Guillaume Lettre, a professor at Université de Montréal's Faculty of Medicine and researcher at the Montreal Heart Institute, co-led the study with professors Joel N. Hirschhorn of...

TLC Announces Collaboration with CMUH in Exploring Solutions for Unmet Medical Needs in Oncology and Osteoarthritis

TLC and China Medical University Hospital (CMUH) signed an agreement on Feb 22 to collaborate in the execution of four clinical trial programs, including two oncology candidate therapeutics and one therapeutic for extended duration osteoarthritis treatment. These drugs were developed by TLC to address unmet medical needs in these areas. By entering a collaboration with the preeminent Clinical...

news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
Asia Pacific Biotech News
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
Obesity / Outlook for 2018
Searching for the fountain of youth
Women in Science - Making a difference
Digestive health in the 21st century - Trust your guts
Dental health - The root to good health
Cancer - Therapies and strategies for better patient outcomes
Water management / Vaccination
Regenerative medicine / Biotech start ups
Digital healthcare / 3D printing
Bones / Breast cancer
Liver health / Top science research nations & institutions
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy